IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Neurobo Pharmaceuticals

CUSIP: 641CVR014 | 3 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

Financial Gravity Companies, Inc.915
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Financial Gravity Companies, Inc.
915$00.0%CoreN/ALakeway, TX2025-08-08